Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
05/1989
05/31/1989EP0317573A1 Antipyretic and anti-inflammatory peptides.
05/30/1989US4835260 Erythropoietin composition
05/30/1989US4835257 Polyoxyethylene glycol
05/30/1989US4835252 Vasoactive intestinal peptide analogs
05/30/1989US4835251 Human relaxin
05/30/1989US4835058 Packing material and process for its production
05/30/1989US4834976 Monoclonal antibodies to pseudomonas aeruginosa flagella
05/30/1989US4834975 Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production
05/30/1989US4834973 Immunological methods for treating mammals
05/30/1989CA1254896A1 Fluorescent indicator dyes for calcium ions
05/30/1989CA1254846A1 Monoclonal antibodies against melanocytes and melanomas
05/30/1989CA1254832A1 Interferon administration vehicles
05/24/1989EP0317387A1 Method for enhancing the milk production of mamals and/or increasing the weight of the litter and improving the post-birth growth
05/24/1989EP0317376A1 Preparation of a concentrate of high-purity human factor IX and of other plasma proteins
05/24/1989EP0317355A2 Dietary compositions and methods using bile salt-activated lipase
05/24/1989EP0317292A2 New antibiotics of the mureidomycin group, their preparation, and their therapeutic use
05/24/1989EP0317278A2 Proteolytic fragments and synthetic peptides that block the binding of von Willebrand factor to the platelet membrane glycoprotein Ib
05/24/1989EP0317053A2 Trigramin- a platelet aggregation inhibiting polypeptide
05/24/1989EP0317050A2 Hepatocyte stimulating factor
05/24/1989EP0316907A2 Enzyme inhibitor and method of producing the same
05/24/1989EP0316818A2 Monoclonal antibodies capable of recognizing N-acetylneuraminic acid in beta-arrangement
05/24/1989EP0316776A2 Monoclonal antibodies to anthracyclines
05/24/1989EP0316769A2 Disulfide bridged cyclic peptides containing a cgridri sequence useful in control of hypertension
05/24/1989EP0316712A2 22-Dechloroteicoplanins
05/24/1989EP0316709A2 Proteinaceous derivatives containing iron in highly bioavailable form, preparation thereof and pharmaceutical compositions containing them
05/24/1989EP0316695A1 Recombinant HIV-2 polypeptides
05/24/1989EP0316463A1 Murine hybridoma lym-1 and diagnostic antibody produced thereby
05/24/1989EP0316425A1 A SV40 EXPRESSION VECTOR CONTAINING HBxAg AS AN EXPRESSION MARKER
05/24/1989EP0316408A1 Method of tumor inhibition in warm-blooded animals
05/24/1989DE3836911A1 Renin inhibitors
05/24/1989DE3737367A1 Vascular anticoagulant proteins, DNA which encode the latter, process for their preparation and their use
05/24/1989CN1033074A Monoclonal antibody specific to a novel epitope of the lfa-1 antigen of human t lymphocytes
05/24/1989CN1033070A Modified plasminogen activators
05/23/1989US4833200 Antithrombogenic medical material and method of preparing same
05/23/1989US4833166 Growth hormone releasing hormone complementary peptides
05/23/1989US4833152 Anti-hypertensive agents
05/23/1989US4833130 Aids treatment with 3'azido-3'-deoxythymidine derivatives
05/23/1989US4833127 Novel CSF and method for obtaining the same
05/23/1989US4833126 Analgestics, antiasthmatics, antitussive agents
05/23/1989US4833125 Method of increasing bone mass
05/23/1989US4833074 Purified human granylocyte L1 proteins methods for their preparation, monospecific antibodies and test kits
05/23/1989US4832959 Preparation of polypeptides having human γ-interferon activity
05/23/1989US4832940 Method of locating or imaging activated T-lymphocytes with a targeting polypeptide
05/23/1989US4832849 Liquid chromatography
05/23/1989US4832686 Method for administering interleukin-2
05/23/1989US4832682 Injection method and apparatus with electrical blood absorbing stimulation
05/23/1989CA1254700A1 Process for preparing biologically active heptapeptides
05/23/1989CA1254699A1 Renin inhibitors containing statine or derivatives thereof
05/23/1989CA1254528A1 Process for encapsulation and encapsulated active material system
05/23/1989CA1254527A1 Expression vectors for enhanced production of polypeptides, plasmids containing the vectors, hosts containing the plasmids, products manufactured thereby and related methods
05/23/1989CA1254510A1 Fibronectin preparations
05/18/1989WO1989004491A1 Urinary assay for measuring bone resorption
05/18/1989WO1989004368A1 Novel human tissue-type plasminogen activator variant
05/18/1989WO1989004326A1 Alveolar surfactant proteins
05/18/1989WO1989004325A1 Neutrophil-activating polypeptide, process for its manufacture and its use as a drug and diagnosticum
05/18/1989WO1989004324A1 Phosphoryled derivatives of cardiodilatine/anf peptides
05/18/1989WO1989004323A1 Hypoglycaemic peptides
05/18/1989WO1989004320A1 PRODUCTION OF ANIMAL LYSOZYME c VIA SECRETION FROM PICHIA PASTORIS AND COMPOSITION THEREFOR
05/18/1989WO1989004177A1 Gamma interferon formulation
05/18/1989WO1989004175A1 Monoclonal antibody specific to a novel epitope of the lfa-1 antigen of human t lymphocytes
05/18/1989WO1989004174A1 Anti-c3bi receptor (cr3) antibodies and therapeutic composition
05/18/1989WO1989004173A1 Acceleration of bone formation with gm-csf
05/18/1989WO1989004172A1 Wound healing composition and method
05/18/1989WO1989004171A1 Protein fraction with immunosuppressive activity, isolated from human seminal plasma
05/18/1989WO1989003846A3 Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
05/18/1989DE3737917A1 Phosphorylierte derivate von cardiodilatin/anf-peptiden Phosphorylated derivatives of cardiodilatin / anf-peptides
05/18/1989DE3737703A1 Neutrophilen aktivierendes polypeptid, verfahren zu dessen herstellung sowie dessen verwendung als arzneimittel und diagnostikum Neutrophil-activating polypeptide moved to its production and its use as a drug and diagnostic use
05/17/1989EP0316218A1 L-proline derivatives, their preparation and biological applications thereof
05/17/1989EP0316212A1 Use of nitrophenyls or anti-nitrophenyl antibodies for modification of the interaction between host-sensitive cells and a pathogenic agent
05/17/1989EP0316170A2 Method for the identification of antigens expressed in vivo, diagnostic assays therefor and vaccines containing them
05/17/1989EP0316068A1 Modified low molecular weight plasminogen activator and method of preparation
05/17/1989EP0316030A1 Vincristine-containing product
05/17/1989EP0315968A1 Plasma and recombinant protein formulations in low ionic strength media
05/17/1989EP0315683A1 Dna sequences, recombinant dna molecules and processes for producing lymphocyte function associated antigen-3
05/17/1989EP0315627A1 A method to treat blood.
05/16/1989US4831184 N-substituted-amido-amino acids
05/16/1989US4831157 Ocrahydrocyclopenta(b)pyrrole-2-carboxylate
05/16/1989US4831120 Method for recovering a purified animal growth hormone or polypeptide analog thereof from a bacterial cell
05/16/1989US4831119 Blood clotting factors
05/16/1989US4831012 Purified hemoglobin solutions and method for making same
05/16/1989US4830962 Expression vectors encoding for a dt-a fragment which use dna control sequences not native to the coding sequences but compatible to the host
05/16/1989US4830857 Cosmetic and pharmaceutical compositions containing niosomes and a water-soluble polyamide, and a process for preparing these compositions
05/16/1989EP0228452A4 Protein purification.
05/16/1989CA1254349A1 Synthesis of hgrf (somatocrinin) in liquid phase
05/16/1989CA1254137A1 Mechanically sheared collagen implant material and method
05/10/1989EP0315574A2 Renin inhibitors
05/10/1989EP0315519A2 Aminopimelic acid derivatives, process for their preparation and their use as medicines
05/10/1989EP0315471A2 Poultry growth promotion
05/10/1989EP0315459A2 HIV incomplete particles and a method for production thereof
05/10/1989EP0315367A2 Polypeptides
05/10/1989EP0315300A2 Treatment of tuberculous and nontuberculous mycobacterial infection
05/10/1989EP0315289A2 Cell growth inhibitory factor
05/10/1989EP0315153A2 Vaccine adjuvant
05/10/1989EP0315118A2 DNA coding for endothelin and use thereof
05/10/1989EP0315110A2 Use of the tumor necrosis factor as adjuvant of the immune response
05/10/1989EP0315081A2 Anti-coagulating protein PP4-x, its preparation and use
05/10/1989EP0314866A2 Novel alkylated hormonereleasing peptides and method of treating mammals therewith
05/10/1989EP0314863A2 Use of ICAM-1 or its functional derivatives for the treatment of non-specific inflammation
05/10/1989EP0314768A1 Method for inducing biological coverings in wounds
05/10/1989EP0314755A1 Use of derivatives of GHL-Cu for the manufacture of a medicament for stimulating hair growth.
1 ... 3058 3059 3060 3061 3062 3063 3064 3065 3066 3067 3068 3069 3070 3071 3072 3073 3074 3075 3076 3077 3078 ... 3163